Feds Hand Madison Mushroom Lab a Golden Ticket in Depression Drug Race
A Madison nonprofit won a federal voucher to speed FDA review of psilocybin for major depression, joining two other programs selected under an April executive order. Local researchers say the award validates years of work but leaves rollout questions.












